IVM for expected high responders: balancing the effectiveness and safety: In Reply
B.W. Mol L.N. Vuong
Review Large randomized controlled trials in infertility
[ Rui Wang, M.D., Ph.D.a, Zi-Jiang Chen, M.D., Ph.D.b,c,d, Lan N. Vuong, M.D., Ph.D.e, Richard S. Legro, M.D.f, Ben W. Mol, M.D., Ph.D.a and Jack Wilkinson, Ph.D.g ]
As the first paper in this series of Views and Reviews on randomized controlled trials (RCTs), we aim to provide the b...
Review Corifollitropin alfa vs recombinant FSH for controlled ovarian stimulation in women aged 35–42 years with a body weight ≥50 kg: a randomized controlled trial
[ N.L. Vuong1,2,*, D.T. Pham2, H.T. Phung2, H.N. Giang2, G.B. Huynh2, T.T.L. Nguyen2, and M.T. Ho2,3 ]
Is corifollitropin alfa 150 μg equivalent to follitropin beta 300 IU/day for controlled ovarian...
Review Development of children born after in vitro maturation with a prematuration step versus natural conception: a prospective cohort study
[ Duy L Nguyen 1, Nghia A Nguyen 1 2, Toan D Pham 1, Minh H N Nguyen 1, Lan N Vuong 3 4 ]
Purpose: IVM preceded by a prematuration step (capacitation [CAPA]-IVM) improves the acquisition of oocyte...
Review POSEIDON groups and their distinct reproductive outcomes: Effectiveness and cost-effectiveness insights from real-world data research
[ Sandro C.Estevesab, HakanYaralic, Lan N.Vuongdef, AlessandroConfortig, PeterHumaidanbh, CarloAlviggig ]
The Patient-Oriented Strategies Enc...
Review Antral follicle count and anti-Müllerian hormone to classify low-prognosis women under the POSEIDON criteria: a classification agreement study of over 9000 patients
[ Sandro C Esteves1, Hakan Yarali2,3, Lan N Vuong4,5,6, José F Carvalho7, İrem Y Özbek2, Mehtap Polat2, Ho L Le4,5, Toan D Pham4,5, Tuong M Ho4,5 ]